TEMOZOLOMIDE FOR RECURRENT INTRACRANIAL EPENDYMOMA OF THE ADULT: PATTERNS OF RESPONSE, SURVIVAL AND CORRELATIONS WITH MGMT PROMOTER METHYLATION

被引:0
|
作者
Soffietti, Riccardo
Bosa, Chiara
Bertero, Luca
Trevisan, Elisa
Cassoni, Paola
Morra, Isabella
Ruda, Roberta
机构
[1] Univ Turin, Dept Neurooncol, Turin, Italy
[2] City Hlth & Sci, Turin, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] TEMOZOLOMIDE FOR RECURRENT INTRACRANIAL EPENDYMOMA OF THE ADULT
    Bosa, C.
    Magistrello, M.
    Trevisan, E.
    Morra, I.
    Fiano, V.
    Dealis, C.
    Ruda, R.
    Soffietti, R.
    NEURO-ONCOLOGY, 2012, 14 : 91 - 91
  • [2] MGMT promoter methylation and temozolomide response in choroid plexus carcinoma
    Kouichi Misaki
    Mitsutoshi Nakada
    Masanao Mohri
    Yutaka Hayashi
    Jun-ichiro Hamada
    Brain Tumor Pathology, 2011, 28 : 259 - 263
  • [3] MGMT promoter methylation and temozolomide response in choroid plexus carcinoma
    Misaki, Kouichi
    Nakada, Mitsutoshi
    Mohri, Masanao
    Hayashi, Yutaka
    Hamada, Jun-ichiro
    BRAIN TUMOR PATHOLOGY, 2011, 28 (03) : 259 - 263
  • [4] Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients
    Kavouridis, Vasileios K.
    Ligon, Keith L.
    Wen, Patrick Y.
    Iorgulescu, J. Bryan
    JOURNAL OF NEURO-ONCOLOGY, 2022, 158 (01) : 111 - 116
  • [5] Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients
    Vasileios K. Kavouridis
    Keith L. Ligon
    Patrick Y. Wen
    J. Bryan Iorgulescu
    Journal of Neuro-Oncology, 2022, 158 : 111 - 116
  • [6] MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma
    Donson, A. M.
    Addo-Yobo, S. O.
    Handler, M. H.
    Gore, L.
    Foreman, N. K.
    NEURO-ONCOLOGY, 2007, 9 (02) : 189 - 189
  • [7] MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma
    Donson, Andrew M.
    Addo-Yobo, Steven O.
    Handler, Michael H.
    Gore, Lia
    Foreman, Nicholas K.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (04) : 403 - 407
  • [8] Recurrent PNET with MGMT Methylation Responds to Temozolomide
    Oh, Jiwon
    Bilbao, Juan M.
    Tsao, May N.
    Fazl, Mahmood
    Guiot, Marie-Christine
    Del Maestro, Rolando F.
    Perry, James R.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2009, 36 (05) : 654 - 657
  • [9] MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma
    Tuominen, Rainer
    Jewell, Rosalyn
    van den Oord, Joost J.
    Wolter, Pascal
    Stierner, Ulrika
    Lindholm, Christer
    Johansson, Carolina Hertzman
    Linden, Diana
    Johansson, Hemming
    Stolt, Marianne Frostvik
    Walker, Christy
    Snowden, Helen
    Newton-Bishop, Julia
    Hansson, Johan
    Brage, Suzanne Egyhazi
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (12) : 2844 - 2853
  • [10] Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide
    K A van Nifterik
    J van den Berg
    W F van der Meide
    N Ameziane
    L E Wedekind
    R D M Steenbergen
    S Leenstra
    M V M Lafleur
    B J Slotman
    L J A Stalpers
    P Sminia
    British Journal of Cancer, 2010, 103 : 29 - 35